Less frequent AEs like hypoglycemia, is mostly seen in combination with insulin or sulfonylureas (157) and some reports of pancreatobiliary complications are partially explained by direct altered absorption of bile acids, rapid weight loss or changes in the gallbladder motility with increased risk of pancreatitis, even though it is extremely rare (160)
A few6 to consider: Efficacy - not all weight loss patients need to lose much weight
Science that's preliminary or disputed By the time Noom entered the GLP-1 business in May 2023, both the Eli Lilly and Novo Nordiskfunded studies, which found that most gain back much of the weight they lost after going off the drugs, had been published
30 tablets
2,3 In addition to these mechanisms, GLP-1 RAs also delay gastric emptying, thereby contributing to enhanced postprandial glucose regulation and increased satiety, ultimately supporting reduced caloric intake and weight management